nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A5—Sorafenib—liver cancer	0.138	0.374	CbGbCtD
Rivaroxaban—ABCB1—Sorafenib—liver cancer	0.0898	0.244	CbGbCtD
Rivaroxaban—ABCB1—Doxorubicin—liver cancer	0.0545	0.148	CbGbCtD
Rivaroxaban—CYP3A4—Sorafenib—liver cancer	0.0538	0.146	CbGbCtD
Rivaroxaban—CYP3A4—Doxorubicin—liver cancer	0.0326	0.0885	CbGbCtD
Rivaroxaban—Lipase increased—Sorafenib—liver cancer	0.0161	0.0481	CcSEcCtD
Rivaroxaban—Amylase increased—Sorafenib—liver cancer	0.00996	0.0297	CcSEcCtD
Rivaroxaban—Embolism venous—Sorafenib—liver cancer	0.0094	0.028	CcSEcCtD
Rivaroxaban—Cerebral haemorrhage—Sorafenib—liver cancer	0.00857	0.0255	CcSEcCtD
Rivaroxaban—Haematoma—Sorafenib—liver cancer	0.00754	0.0225	CcSEcCtD
Rivaroxaban—Venous thromboembolism—Epirubicin—liver cancer	0.00596	0.0178	CcSEcCtD
Rivaroxaban—Myocardial ischaemia—Sorafenib—liver cancer	0.0059	0.0176	CcSEcCtD
Rivaroxaban—Venous thromboembolism—Doxorubicin—liver cancer	0.00552	0.0164	CcSEcCtD
Rivaroxaban—Blood bilirubin increased—Sorafenib—liver cancer	0.00501	0.0149	CcSEcCtD
Rivaroxaban—Hepatic function abnormal—Sorafenib—liver cancer	0.00394	0.0117	CcSEcCtD
Rivaroxaban—Renal failure acute—Sorafenib—liver cancer	0.00373	0.0111	CcSEcCtD
Rivaroxaban—Embolism venous—Epirubicin—liver cancer	0.00347	0.0103	CcSEcCtD
Rivaroxaban—Pain in extremity—Sorafenib—liver cancer	0.00344	0.0103	CcSEcCtD
Rivaroxaban—Lactic dehydrogenase activity increased—Epirubicin—liver cancer	0.00342	0.0102	CcSEcCtD
Rivaroxaban—Embolism venous—Doxorubicin—liver cancer	0.00321	0.00957	CcSEcCtD
Rivaroxaban—Lactic dehydrogenase activity increased—Doxorubicin—liver cancer	0.00317	0.00944	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Sorafenib—liver cancer	0.00314	0.00937	CcSEcCtD
Rivaroxaban—Gingival bleeding—Epirubicin—liver cancer	0.00309	0.0092	CcSEcCtD
Rivaroxaban—Blood lactate dehydrogenase increased—Epirubicin—liver cancer	0.00302	0.00898	CcSEcCtD
Rivaroxaban—Gingival bleeding—Doxorubicin—liver cancer	0.00286	0.00851	CcSEcCtD
Rivaroxaban—Thrombocytosis—Epirubicin—liver cancer	0.00282	0.0084	CcSEcCtD
Rivaroxaban—Blood lactate dehydrogenase increased—Doxorubicin—liver cancer	0.00279	0.00831	CcSEcCtD
Rivaroxaban—Infestation—Sorafenib—liver cancer	0.00265	0.0079	CcSEcCtD
Rivaroxaban—Infestation NOS—Sorafenib—liver cancer	0.00265	0.0079	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00263	0.00784	CcSEcCtD
Rivaroxaban—Thrombocytosis—Doxorubicin—liver cancer	0.00261	0.00777	CcSEcCtD
Rivaroxaban—Renal failure—Sorafenib—liver cancer	0.00261	0.00777	CcSEcCtD
Rivaroxaban—Jaundice—Sorafenib—liver cancer	0.00259	0.0077	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Sorafenib—liver cancer	0.00251	0.00747	CcSEcCtD
Rivaroxaban—Epistaxis—Sorafenib—liver cancer	0.0025	0.00745	CcSEcCtD
Rivaroxaban—Blister—Epirubicin—liver cancer	0.00243	0.00724	CcSEcCtD
Rivaroxaban—Haemoglobin—Sorafenib—liver cancer	0.00239	0.00713	CcSEcCtD
Rivaroxaban—Haemorrhage—Sorafenib—liver cancer	0.00238	0.00709	CcSEcCtD
Rivaroxaban—Dermatitis atopic—Epirubicin—liver cancer	0.00237	0.00705	CcSEcCtD
Rivaroxaban—Haemoptysis—Epirubicin—liver cancer	0.00237	0.00705	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Sorafenib—liver cancer	0.00235	0.00701	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Sorafenib—liver cancer	0.00234	0.00697	CcSEcCtD
Rivaroxaban—Urethral disorder—Sorafenib—liver cancer	0.00233	0.00695	CcSEcCtD
Rivaroxaban—Erythema multiforme—Sorafenib—liver cancer	0.00225	0.00671	CcSEcCtD
Rivaroxaban—Blister—Doxorubicin—liver cancer	0.00225	0.0067	CcSEcCtD
Rivaroxaban—Cardiac disorder—Sorafenib—liver cancer	0.00221	0.00658	CcSEcCtD
Rivaroxaban—Dermatitis atopic—Doxorubicin—liver cancer	0.00219	0.00653	CcSEcCtD
Rivaroxaban—Haemoptysis—Doxorubicin—liver cancer	0.00219	0.00653	CcSEcCtD
Rivaroxaban—Angiopathy—Sorafenib—liver cancer	0.00216	0.00644	CcSEcCtD
Rivaroxaban—Immune system disorder—Sorafenib—liver cancer	0.00215	0.00641	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Sorafenib—liver cancer	0.00215	0.00639	CcSEcCtD
Rivaroxaban—Muscle spasms—Sorafenib—liver cancer	0.00199	0.00594	CcSEcCtD
Rivaroxaban—Rectal haemorrhage—Epirubicin—liver cancer	0.00194	0.00578	CcSEcCtD
Rivaroxaban—Anaemia—Sorafenib—liver cancer	0.00192	0.00571	CcSEcCtD
Rivaroxaban—Angioedema—Sorafenib—liver cancer	0.00189	0.00564	CcSEcCtD
Rivaroxaban—Syncope—Sorafenib—liver cancer	0.00186	0.00554	CcSEcCtD
Rivaroxaban—Blood bilirubin increased—Epirubicin—liver cancer	0.00185	0.00552	CcSEcCtD
Rivaroxaban—Loss of consciousness—Sorafenib—liver cancer	0.00182	0.00543	CcSEcCtD
Rivaroxaban—Rectal haemorrhage—Doxorubicin—liver cancer	0.0018	0.00535	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00175	0.00522	CcSEcCtD
Rivaroxaban—Dry mouth—Sorafenib—liver cancer	0.00173	0.00514	CcSEcCtD
Rivaroxaban—Blood bilirubin increased—Doxorubicin—liver cancer	0.00171	0.00511	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Sorafenib—liver cancer	0.00169	0.00504	CcSEcCtD
Rivaroxaban—Infection—Sorafenib—liver cancer	0.00168	0.00501	CcSEcCtD
Rivaroxaban—Shock—Sorafenib—liver cancer	0.00166	0.00496	CcSEcCtD
Rivaroxaban—Nervous system disorder—Sorafenib—liver cancer	0.00166	0.00494	CcSEcCtD
Rivaroxaban—Blood urea increased—Epirubicin—liver cancer	0.00165	0.00493	CcSEcCtD
Rivaroxaban—Skin disorder—Sorafenib—liver cancer	0.00164	0.0049	CcSEcCtD
Rivaroxaban—Ecchymosis—Epirubicin—liver cancer	0.00158	0.00472	CcSEcCtD
Rivaroxaban—Blood urea increased—Doxorubicin—liver cancer	0.00153	0.00456	CcSEcCtD
Rivaroxaban—Dyspnoea—Sorafenib—liver cancer	0.00151	0.00449	CcSEcCtD
Rivaroxaban—Dyspepsia—Sorafenib—liver cancer	0.00149	0.00444	CcSEcCtD
Rivaroxaban—Ecchymosis—Doxorubicin—liver cancer	0.00147	0.00437	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Sorafenib—liver cancer	0.00146	0.00435	CcSEcCtD
Rivaroxaban—Fatigue—Sorafenib—liver cancer	0.00146	0.00435	CcSEcCtD
Rivaroxaban—Hepatic function abnormal—Epirubicin—liver cancer	0.00146	0.00434	CcSEcCtD
Rivaroxaban—Pain—Sorafenib—liver cancer	0.00145	0.00431	CcSEcCtD
Rivaroxaban—Constipation—Sorafenib—liver cancer	0.00145	0.00431	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Sorafenib—liver cancer	0.00138	0.00412	CcSEcCtD
Rivaroxaban—Renal failure acute—Epirubicin—liver cancer	0.00138	0.00411	CcSEcCtD
Rivaroxaban—Hepatic function abnormal—Doxorubicin—liver cancer	0.00135	0.00401	CcSEcCtD
Rivaroxaban—Urticaria—Sorafenib—liver cancer	0.00134	0.004	CcSEcCtD
Rivaroxaban—Abdominal pain—Sorafenib—liver cancer	0.00134	0.00398	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Epirubicin—liver cancer	0.00133	0.00397	CcSEcCtD
Rivaroxaban—Renal failure acute—Doxorubicin—liver cancer	0.00127	0.0038	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00127	0.00379	CcSEcCtD
Rivaroxaban—Pain in extremity—Epirubicin—liver cancer	0.00127	0.00379	CcSEcCtD
Rivaroxaban—Osteoarthritis—Epirubicin—liver cancer	0.00127	0.00379	CcSEcCtD
Rivaroxaban—Hypersensitivity—Sorafenib—liver cancer	0.00125	0.00371	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Doxorubicin—liver cancer	0.00123	0.00367	CcSEcCtD
Rivaroxaban—Asthenia—Sorafenib—liver cancer	0.00121	0.00362	CcSEcCtD
Rivaroxaban—Pruritus—Sorafenib—liver cancer	0.0012	0.00357	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Epirubicin—liver cancer	0.00119	0.00355	CcSEcCtD
Rivaroxaban—Osteoarthritis—Doxorubicin—liver cancer	0.00118	0.00351	CcSEcCtD
Rivaroxaban—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00118	0.00351	CcSEcCtD
Rivaroxaban—Pain in extremity—Doxorubicin—liver cancer	0.00118	0.00351	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Epirubicin—liver cancer	0.00116	0.00346	CcSEcCtD
Rivaroxaban—Diarrhoea—Sorafenib—liver cancer	0.00116	0.00345	CcSEcCtD
Rivaroxaban—Dizziness—Sorafenib—liver cancer	0.00112	0.00333	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Doxorubicin—liver cancer	0.0011	0.00329	CcSEcCtD
Rivaroxaban—Vomiting—Sorafenib—liver cancer	0.00108	0.0032	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Doxorubicin—liver cancer	0.00108	0.0032	CcSEcCtD
Rivaroxaban—Angina pectoris—Epirubicin—liver cancer	0.00107	0.00319	CcSEcCtD
Rivaroxaban—Rash—Sorafenib—liver cancer	0.00107	0.00318	CcSEcCtD
Rivaroxaban—Dermatitis—Sorafenib—liver cancer	0.00107	0.00318	CcSEcCtD
Rivaroxaban—Headache—Sorafenib—liver cancer	0.00106	0.00316	CcSEcCtD
Rivaroxaban—Nausea—Sorafenib—liver cancer	0.001	0.00299	CcSEcCtD
Rivaroxaban—Angina pectoris—Doxorubicin—liver cancer	0.000991	0.00295	CcSEcCtD
Rivaroxaban—Infestation NOS—Epirubicin—liver cancer	0.00098	0.00292	CcSEcCtD
Rivaroxaban—Infestation—Epirubicin—liver cancer	0.00098	0.00292	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000972	0.0029	CcSEcCtD
Rivaroxaban—Renal failure—Epirubicin—liver cancer	0.000964	0.00287	CcSEcCtD
Rivaroxaban—Jaundice—Epirubicin—liver cancer	0.000956	0.00285	CcSEcCtD
Rivaroxaban—Urinary tract infection—Epirubicin—liver cancer	0.000953	0.00284	CcSEcCtD
Rivaroxaban—Haematuria—Epirubicin—liver cancer	0.000935	0.00278	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Epirubicin—liver cancer	0.000927	0.00276	CcSEcCtD
Rivaroxaban—Epistaxis—Epirubicin—liver cancer	0.000925	0.00275	CcSEcCtD
Rivaroxaban—Sinusitis—Epirubicin—liver cancer	0.00092	0.00274	CcSEcCtD
Rivaroxaban—Agranulocytosis—Epirubicin—liver cancer	0.000915	0.00273	CcSEcCtD
Rivaroxaban—Infestation NOS—Doxorubicin—liver cancer	0.000907	0.0027	CcSEcCtD
Rivaroxaban—Infestation—Doxorubicin—liver cancer	0.000907	0.0027	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000899	0.00268	CcSEcCtD
Rivaroxaban—Renal failure—Doxorubicin—liver cancer	0.000892	0.00266	CcSEcCtD
Rivaroxaban—Haemoglobin—Epirubicin—liver cancer	0.000885	0.00264	CcSEcCtD
Rivaroxaban—Jaundice—Doxorubicin—liver cancer	0.000884	0.00263	CcSEcCtD
Rivaroxaban—Urinary tract infection—Doxorubicin—liver cancer	0.000882	0.00263	CcSEcCtD
Rivaroxaban—Haemorrhage—Epirubicin—liver cancer	0.00088	0.00262	CcSEcCtD
Rivaroxaban—Hepatitis—Epirubicin—liver cancer	0.00088	0.00262	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Epirubicin—liver cancer	0.000869	0.00259	CcSEcCtD
Rivaroxaban—Haematuria—Doxorubicin—liver cancer	0.000865	0.00258	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Epirubicin—liver cancer	0.000865	0.00258	CcSEcCtD
Rivaroxaban—Urethral disorder—Epirubicin—liver cancer	0.000863	0.00257	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Doxorubicin—liver cancer	0.000858	0.00256	CcSEcCtD
Rivaroxaban—Epistaxis—Doxorubicin—liver cancer	0.000856	0.00255	CcSEcCtD
Rivaroxaban—Sinusitis—Doxorubicin—liver cancer	0.000851	0.00254	CcSEcCtD
Rivaroxaban—Agranulocytosis—Doxorubicin—liver cancer	0.000847	0.00252	CcSEcCtD
Rivaroxaban—Erythema multiforme—Epirubicin—liver cancer	0.000832	0.00248	CcSEcCtD
Rivaroxaban—Eye disorder—Epirubicin—liver cancer	0.000822	0.00245	CcSEcCtD
Rivaroxaban—Haemoglobin—Doxorubicin—liver cancer	0.000818	0.00244	CcSEcCtD
Rivaroxaban—Cardiac disorder—Epirubicin—liver cancer	0.000817	0.00243	CcSEcCtD
Rivaroxaban—Hepatitis—Doxorubicin—liver cancer	0.000814	0.00243	CcSEcCtD
Rivaroxaban—Haemorrhage—Doxorubicin—liver cancer	0.000814	0.00243	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Doxorubicin—liver cancer	0.000804	0.0024	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Doxorubicin—liver cancer	0.0008	0.00238	CcSEcCtD
Rivaroxaban—Angiopathy—Epirubicin—liver cancer	0.000798	0.00238	CcSEcCtD
Rivaroxaban—Urethral disorder—Doxorubicin—liver cancer	0.000798	0.00238	CcSEcCtD
Rivaroxaban—Immune system disorder—Epirubicin—liver cancer	0.000795	0.00237	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Epirubicin—liver cancer	0.000793	0.00236	CcSEcCtD
Rivaroxaban—Erythema multiforme—Doxorubicin—liver cancer	0.00077	0.00229	CcSEcCtD
Rivaroxaban—Eye disorder—Doxorubicin—liver cancer	0.000761	0.00227	CcSEcCtD
Rivaroxaban—Cardiac disorder—Doxorubicin—liver cancer	0.000756	0.00225	CcSEcCtD
Rivaroxaban—Back pain—Epirubicin—liver cancer	0.000741	0.00221	CcSEcCtD
Rivaroxaban—Angiopathy—Doxorubicin—liver cancer	0.000739	0.0022	CcSEcCtD
Rivaroxaban—Muscle spasms—Epirubicin—liver cancer	0.000737	0.00219	CcSEcCtD
Rivaroxaban—Immune system disorder—Doxorubicin—liver cancer	0.000736	0.00219	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Doxorubicin—liver cancer	0.000734	0.00219	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Epirubicin—liver cancer	0.000711	0.00212	CcSEcCtD
Rivaroxaban—Anaemia—Epirubicin—liver cancer	0.000708	0.00211	CcSEcCtD
Rivaroxaban—Malaise—Epirubicin—liver cancer	0.000691	0.00206	CcSEcCtD
Rivaroxaban—Syncope—Epirubicin—liver cancer	0.000687	0.00205	CcSEcCtD
Rivaroxaban—Back pain—Doxorubicin—liver cancer	0.000686	0.00204	CcSEcCtD
Rivaroxaban—Muscle spasms—Doxorubicin—liver cancer	0.000682	0.00203	CcSEcCtD
Rivaroxaban—Loss of consciousness—Epirubicin—liver cancer	0.000673	0.00201	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Doxorubicin—liver cancer	0.000658	0.00196	CcSEcCtD
Rivaroxaban—Anaemia—Doxorubicin—liver cancer	0.000655	0.00195	CcSEcCtD
Rivaroxaban—Chest pain—Epirubicin—liver cancer	0.000652	0.00194	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000648	0.00193	CcSEcCtD
Rivaroxaban—Discomfort—Epirubicin—liver cancer	0.000644	0.00192	CcSEcCtD
Rivaroxaban—Malaise—Doxorubicin—liver cancer	0.000639	0.0019	CcSEcCtD
Rivaroxaban—Dry mouth—Epirubicin—liver cancer	0.000638	0.0019	CcSEcCtD
Rivaroxaban—Syncope—Doxorubicin—liver cancer	0.000636	0.00189	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Epirubicin—liver cancer	0.000625	0.00186	CcSEcCtD
Rivaroxaban—Oedema—Epirubicin—liver cancer	0.000625	0.00186	CcSEcCtD
Rivaroxaban—Loss of consciousness—Doxorubicin—liver cancer	0.000623	0.00186	CcSEcCtD
Rivaroxaban—Infection—Epirubicin—liver cancer	0.000621	0.00185	CcSEcCtD
Rivaroxaban—Shock—Epirubicin—liver cancer	0.000615	0.00183	CcSEcCtD
Rivaroxaban—Nervous system disorder—Epirubicin—liver cancer	0.000613	0.00183	CcSEcCtD
Rivaroxaban—Tachycardia—Epirubicin—liver cancer	0.00061	0.00182	CcSEcCtD
Rivaroxaban—Skin disorder—Epirubicin—liver cancer	0.000607	0.00181	CcSEcCtD
Rivaroxaban—Chest pain—Doxorubicin—liver cancer	0.000604	0.0018	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000599	0.00179	CcSEcCtD
Rivaroxaban—Discomfort—Doxorubicin—liver cancer	0.000596	0.00178	CcSEcCtD
Rivaroxaban—Dry mouth—Doxorubicin—liver cancer	0.00059	0.00176	CcSEcCtD
Rivaroxaban—Hypotension—Epirubicin—liver cancer	0.000584	0.00174	CcSEcCtD
Rivaroxaban—Oedema—Doxorubicin—liver cancer	0.000579	0.00172	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Doxorubicin—liver cancer	0.000579	0.00172	CcSEcCtD
Rivaroxaban—Infection—Doxorubicin—liver cancer	0.000575	0.00171	CcSEcCtD
Rivaroxaban—Shock—Doxorubicin—liver cancer	0.000569	0.0017	CcSEcCtD
Rivaroxaban—Nervous system disorder—Doxorubicin—liver cancer	0.000567	0.00169	CcSEcCtD
Rivaroxaban—Tachycardia—Doxorubicin—liver cancer	0.000565	0.00168	CcSEcCtD
Rivaroxaban—Skin disorder—Doxorubicin—liver cancer	0.000562	0.00167	CcSEcCtD
Rivaroxaban—Dyspnoea—Epirubicin—liver cancer	0.000557	0.00166	CcSEcCtD
Rivaroxaban—Dyspepsia—Epirubicin—liver cancer	0.00055	0.00164	CcSEcCtD
Rivaroxaban—Hypotension—Doxorubicin—liver cancer	0.000541	0.00161	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Epirubicin—liver cancer	0.00054	0.00161	CcSEcCtD
Rivaroxaban—Fatigue—Epirubicin—liver cancer	0.000539	0.00161	CcSEcCtD
Rivaroxaban—Pain—Epirubicin—liver cancer	0.000535	0.00159	CcSEcCtD
Rivaroxaban—Constipation—Epirubicin—liver cancer	0.000535	0.00159	CcSEcCtD
Rivaroxaban—Dyspnoea—Doxorubicin—liver cancer	0.000516	0.00154	CcSEcCtD
Rivaroxaban—Feeling abnormal—Epirubicin—liver cancer	0.000515	0.00154	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Epirubicin—liver cancer	0.000511	0.00152	CcSEcCtD
Rivaroxaban—Dyspepsia—Doxorubicin—liver cancer	0.000509	0.00152	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000499	0.00149	CcSEcCtD
Rivaroxaban—Fatigue—Doxorubicin—liver cancer	0.000499	0.00149	CcSEcCtD
Rivaroxaban—Urticaria—Epirubicin—liver cancer	0.000497	0.00148	CcSEcCtD
Rivaroxaban—Pain—Doxorubicin—liver cancer	0.000495	0.00147	CcSEcCtD
Rivaroxaban—Constipation—Doxorubicin—liver cancer	0.000495	0.00147	CcSEcCtD
Rivaroxaban—Abdominal pain—Epirubicin—liver cancer	0.000494	0.00147	CcSEcCtD
Rivaroxaban—Feeling abnormal—Doxorubicin—liver cancer	0.000477	0.00142	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Doxorubicin—liver cancer	0.000473	0.00141	CcSEcCtD
Rivaroxaban—Hypersensitivity—Epirubicin—liver cancer	0.000461	0.00137	CcSEcCtD
Rivaroxaban—Urticaria—Doxorubicin—liver cancer	0.00046	0.00137	CcSEcCtD
Rivaroxaban—Abdominal pain—Doxorubicin—liver cancer	0.000457	0.00136	CcSEcCtD
Rivaroxaban—Asthenia—Epirubicin—liver cancer	0.000449	0.00134	CcSEcCtD
Rivaroxaban—Pruritus—Epirubicin—liver cancer	0.000442	0.00132	CcSEcCtD
Rivaroxaban—Diarrhoea—Epirubicin—liver cancer	0.000428	0.00127	CcSEcCtD
Rivaroxaban—Hypersensitivity—Doxorubicin—liver cancer	0.000426	0.00127	CcSEcCtD
Rivaroxaban—Asthenia—Doxorubicin—liver cancer	0.000415	0.00124	CcSEcCtD
Rivaroxaban—Dizziness—Epirubicin—liver cancer	0.000413	0.00123	CcSEcCtD
Rivaroxaban—Pruritus—Doxorubicin—liver cancer	0.000409	0.00122	CcSEcCtD
Rivaroxaban—F10—Hemostasis—IGF2—liver cancer	0.000408	0.00138	CbGpPWpGaD
Rivaroxaban—Vomiting—Epirubicin—liver cancer	0.000398	0.00118	CcSEcCtD
Rivaroxaban—Diarrhoea—Doxorubicin—liver cancer	0.000396	0.00118	CcSEcCtD
Rivaroxaban—Rash—Epirubicin—liver cancer	0.000394	0.00117	CcSEcCtD
Rivaroxaban—Dermatitis—Epirubicin—liver cancer	0.000394	0.00117	CcSEcCtD
Rivaroxaban—Headache—Epirubicin—liver cancer	0.000392	0.00117	CcSEcCtD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000391	0.00132	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000391	0.00132	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GLUL—liver cancer	0.000386	0.00131	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CPT1B—liver cancer	0.000386	0.00131	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—HGF—liver cancer	0.000385	0.0013	CbGpPWpGaD
Rivaroxaban—Dizziness—Doxorubicin—liver cancer	0.000383	0.00114	CcSEcCtD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000382	0.00129	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.000382	0.00129	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CSF2—liver cancer	0.000381	0.00129	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NR1H4—liver cancer	0.000372	0.00126	CbGpPWpGaD
Rivaroxaban—Nausea—Epirubicin—liver cancer	0.000371	0.00111	CcSEcCtD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—TERT—liver cancer	0.000371	0.00125	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000369	0.00125	CbGpPWpGaD
Rivaroxaban—Vomiting—Doxorubicin—liver cancer	0.000368	0.0011	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—GSTA3—liver cancer	0.000366	0.00124	CbGpPWpGaD
Rivaroxaban—Rash—Doxorubicin—liver cancer	0.000365	0.00109	CcSEcCtD
Rivaroxaban—Dermatitis—Doxorubicin—liver cancer	0.000364	0.00109	CcSEcCtD
Rivaroxaban—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000364	0.00123	CbGpPWpGaD
Rivaroxaban—Headache—Doxorubicin—liver cancer	0.000362	0.00108	CcSEcCtD
Rivaroxaban—Nausea—Doxorubicin—liver cancer	0.000344	0.00102	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—CYP2E1—liver cancer	0.000342	0.00116	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—CYP2E1—liver cancer	0.000337	0.00114	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTA4—liver cancer	0.000335	0.00113	CbGpPWpGaD
Rivaroxaban—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000328	0.00111	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000327	0.00111	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTA2—liver cancer	0.000326	0.0011	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—IGF2—liver cancer	0.000321	0.00108	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000316	0.00107	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTA1—liver cancer	0.000315	0.00106	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—GGT1—liver cancer	0.000314	0.00106	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NAT2—liver cancer	0.000311	0.00105	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—MAPK14—liver cancer	0.000308	0.00104	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000299	0.00101	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000299	0.00101	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—F2—liver cancer	0.000299	0.00101	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALDOB—liver cancer	0.000298	0.00101	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.000297	0.001	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000292	0.000986	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.000291	0.000984	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000287	0.00097	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PIK3CG—liver cancer	0.000286	0.000967	CbGpPWpGaD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	0.000285	0.000964	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CRABP1—liver cancer	0.000285	0.000962	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000283	0.000956	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—GSTP1—liver cancer	0.000282	0.000953	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—GSTP1—liver cancer	0.000278	0.00094	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	0.000272	0.000918	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000265	0.000896	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000262	0.000887	CbGpPWpGaD
Rivaroxaban—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000262	0.000885	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—GSTM1—liver cancer	0.000259	0.000876	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000259	0.000875	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000256	0.000867	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000256	0.000864	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—GSTM1—liver cancer	0.000256	0.000864	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PIK3CD—liver cancer	0.000251	0.00085	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—HPGDS—liver cancer	0.000249	0.000841	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SERPINE1—liver cancer	0.000249	0.000841	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—ALB—liver cancer	0.000248	0.000839	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000247	0.000836	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000247	0.000834	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—CYP1A1—liver cancer	0.000246	0.00083	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000244	0.000825	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metapathway biotransformation—CYP1A1—liver cancer	0.000242	0.000819	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000241	0.000813	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—F2—liver cancer	0.000235	0.000795	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000225	0.000762	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—RAF1—liver cancer	0.000224	0.000759	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000222	0.000752	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PSMA4—liver cancer	0.000222	0.00075	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PSMD10—liver cancer	0.000222	0.00075	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PIK3CB—liver cancer	0.000219	0.000741	CbGpPWpGaD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	0.000218	0.000737	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GOT2—liver cancer	0.000216	0.000729	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000215	0.000727	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	0.000214	0.000723	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000205	0.000691	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP2E1—liver cancer	0.000203	0.000686	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IL2—liver cancer	0.000201	0.00068	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.0002	0.000676	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—MMP2—liver cancer	0.000199	0.000674	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000196	0.000664	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000195	0.000659	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.000191	0.000646	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000191	0.000645	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CASP3—liver cancer	0.000191	0.000645	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL2—liver cancer	0.00019	0.000644	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYCS—liver cancer	0.00019	0.000642	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	0.000187	0.000632	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GOT1—liver cancer	0.000186	0.00063	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GGT1—liver cancer	0.000186	0.00063	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—UGDH—liver cancer	0.000184	0.000621	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000183	0.000618	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000183	0.000618	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000173	0.000585	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—EPT1—liver cancer	0.000173	0.000584	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—VEGFA—liver cancer	0.000171	0.000578	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTP1—liver cancer	0.000167	0.000566	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—HMOX1—liver cancer	0.000165	0.000558	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000164	0.000555	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—TAT—liver cancer	0.000164	0.000554	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—VEGFA—liver cancer	0.000162	0.000547	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000159	0.000537	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TGFB1—liver cancer	0.000157	0.000531	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000157	0.00053	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTM1—liver cancer	0.000154	0.00052	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CTNNB1—liver cancer	0.000153	0.000517	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TGFB1—liver cancer	0.000149	0.000502	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000146	0.000493	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP1A1—liver cancer	0.000146	0.000493	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—KRAS—liver cancer	0.000145	0.000492	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000144	0.000487	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000141	0.000477	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—liver cancer	0.000139	0.000469	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—UGDH—liver cancer	0.000139	0.000469	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—MTHFR—liver cancer	0.000136	0.000459	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PIK3CA—liver cancer	0.000134	0.000452	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000134	0.000451	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARA—liver cancer	0.000133	0.000451	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000131	0.000443	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—EPT1—liver cancer	0.00013	0.000441	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000129	0.000437	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TP53—liver cancer	0.000129	0.000437	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—HRAS—liver cancer	0.000124	0.000418	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TAT—liver cancer	0.000124	0.000418	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.00012	0.000407	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.00012	0.000405	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	0.000119	0.000403	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000119	0.000402	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000114	0.000386	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CG—liver cancer	0.000114	0.000386	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000113	0.000381	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CPT1B—liver cancer	0.000111	0.000376	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GLUL—liver cancer	0.000111	0.000376	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARG—liver cancer	0.00011	0.000372	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—AKT1—liver cancer	0.000109	0.000369	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NR1H4—liver cancer	0.000107	0.000363	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTA3—liver cancer	0.000106	0.000357	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000105	0.000354	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CD—liver cancer	0.0001	0.000339	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALB—liver cancer	9.91e-05	0.000335	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTA4—liver cancer	9.65e-05	0.000326	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	9.6e-05	0.000325	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	9.41e-05	0.000318	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTA2—liver cancer	9.4e-05	0.000318	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	9.16e-05	0.00031	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	9.14e-05	0.000309	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTA1—liver cancer	9.07e-05	0.000307	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	9.07e-05	0.000307	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NAT2—liver cancer	8.97e-05	0.000303	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	8.86e-05	0.0003	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	8.81e-05	0.000298	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CB—liver cancer	8.75e-05	0.000296	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	8.65e-05	0.000292	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDOB—liver cancer	8.6e-05	0.000291	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—UGDH—liver cancer	8.54e-05	0.000289	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CPT1B—liver cancer	8.4e-05	0.000284	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GLUL—liver cancer	8.4e-05	0.000284	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CRABP1—liver cancer	8.21e-05	0.000277	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NR1H4—liver cancer	8.1e-05	0.000274	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—EPT1—liver cancer	8.03e-05	0.000271	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	7.98e-05	0.00027	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA3—liver cancer	7.96e-05	0.000269	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	7.66e-05	0.000259	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TAT—liver cancer	7.61e-05	0.000257	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	7.35e-05	0.000248	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	7.33e-05	0.000248	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA4—liver cancer	7.28e-05	0.000246	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HPGDS—liver cancer	7.17e-05	0.000242	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA2—liver cancer	7.1e-05	0.00024	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA1—liver cancer	6.85e-05	0.000231	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	6.84e-05	0.000231	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	6.79e-05	0.000229	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NAT2—liver cancer	6.77e-05	0.000229	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDOB—liver cancer	6.49e-05	0.000219	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PSMD10—liver cancer	6.39e-05	0.000216	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PSMA4—liver cancer	6.39e-05	0.000216	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	6.24e-05	0.000211	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GOT2—liver cancer	6.22e-05	0.00021	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CRABP1—liver cancer	6.19e-05	0.000209	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	6.19e-05	0.000209	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	6.03e-05	0.000204	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2E1—liver cancer	5.85e-05	0.000198	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYCS—liver cancer	5.47e-05	0.000185	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HPGDS—liver cancer	5.41e-05	0.000183	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GOT1—liver cancer	5.37e-05	0.000181	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GGT1—liver cancer	5.37e-05	0.000181	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CA—liver cancer	5.33e-05	0.00018	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CPT1B—liver cancer	5.17e-05	0.000175	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GLUL—liver cancer	5.17e-05	0.000175	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	5.09e-05	0.000172	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NR1H4—liver cancer	4.99e-05	0.000169	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA3—liver cancer	4.91e-05	0.000166	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PSMD10—liver cancer	4.82e-05	0.000163	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PSMA4—liver cancer	4.82e-05	0.000163	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTP1—liver cancer	4.82e-05	0.000163	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HMOX1—liver cancer	4.76e-05	0.000161	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GOT2—liver cancer	4.69e-05	0.000159	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	4.6e-05	0.000156	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA4—liver cancer	4.49e-05	0.000152	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTM1—liver cancer	4.43e-05	0.00015	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2E1—liver cancer	4.41e-05	0.000149	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA2—liver cancer	4.37e-05	0.000148	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AKT1—liver cancer	4.36e-05	0.000147	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA1—liver cancer	4.22e-05	0.000143	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP1A1—liver cancer	4.2e-05	0.000142	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NAT2—liver cancer	4.17e-05	0.000141	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	4.16e-05	0.000141	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYCS—liver cancer	4.13e-05	0.00014	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GGT1—liver cancer	4.05e-05	0.000137	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GOT1—liver cancer	4.05e-05	0.000137	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDOB—liver cancer	4e-05	0.000135	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTHFR—liver cancer	3.92e-05	0.000132	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARA—liver cancer	3.84e-05	0.00013	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CRABP1—liver cancer	3.81e-05	0.000129	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTP1—liver cancer	3.64e-05	0.000123	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HMOX1—liver cancer	3.59e-05	0.000121	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTM1—liver cancer	3.34e-05	0.000113	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HPGDS—liver cancer	3.33e-05	0.000113	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CG—liver cancer	3.29e-05	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—liver cancer	3.18e-05	0.000107	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP1A1—liver cancer	3.17e-05	0.000107	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PSMA4—liver cancer	2.97e-05	0.0001	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PSMD10—liver cancer	2.97e-05	0.0001	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTHFR—liver cancer	2.96e-05	9.99e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARA—liver cancer	2.9e-05	9.8e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CD—liver cancer	2.89e-05	9.78e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GOT2—liver cancer	2.89e-05	9.77e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—liver cancer	2.86e-05	9.65e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2E1—liver cancer	2.72e-05	9.19e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYCS—liver cancer	2.54e-05	8.6e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CB—liver cancer	2.52e-05	8.52e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GGT1—liver cancer	2.5e-05	8.44e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GOT1—liver cancer	2.5e-05	8.44e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CG—liver cancer	2.48e-05	8.39e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—liver cancer	2.4e-05	8.1e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTP1—liver cancer	2.24e-05	7.58e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HMOX1—liver cancer	2.21e-05	7.47e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CD—liver cancer	2.18e-05	7.38e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—liver cancer	2.15e-05	7.28e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTM1—liver cancer	2.06e-05	6.96e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP1A1—liver cancer	1.95e-05	6.6e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CB—liver cancer	1.9e-05	6.43e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTHFR—liver cancer	1.82e-05	6.15e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARA—liver cancer	1.79e-05	6.04e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CA—liver cancer	1.54e-05	5.2e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CG—liver cancer	1.53e-05	5.17e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—liver cancer	1.48e-05	4.99e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CD—liver cancer	1.34e-05	4.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—liver cancer	1.33e-05	4.49e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKT1—liver cancer	1.26e-05	4.24e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CB—liver cancer	1.17e-05	3.96e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CA—liver cancer	1.16e-05	3.92e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKT1—liver cancer	9.47e-06	3.2e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CA—liver cancer	7.15e-06	2.42e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKT1—liver cancer	5.84e-06	1.97e-05	CbGpPWpGaD
